Article
Meta-analysis demonstrates no association between p53 codon 72 polymorphism and prostate cancer risk.
Genetics and molecular research : GMR - 29 Nov 2011
Li M S, Liu J L, Wu Y, Wang P, Teng H
Abstract excerpt
We examined whether p53 codon 72 polymorphism confers prostate cancer risk by conducting a meta-analysis. Two investigators independently searched the Pubmed, Embase and CBM databases. This meta-analysis was made of seven case-control studies, that included 892 prostate cancer cases and 1020 healthy controls. Meta-analysis results based on all the studies showed no significant association between p53 codon...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.